Sunovion Plans To Lay Off 360 Employees in 2023
MARLBOROUGH – Headquartered in Marlborough, Sunovion Pharmaceuticals Inc. plans to layoff hundreds of employees in the new year. The pharmaceutical
Read more
Sunovion
Peer Teaching Program Between AMSA & Sunovion Neuroscience Reaches 500+ Students
In full transparency, the following press release was submitted to SOURCE media through its business wire service. *** MARLBOROUGH –
Read more
Urovant Sciences & Sunovion Pharmaceuticals Launch Promotion of GEMTESA For Overactive Bladder Patients
In full transparency, the following press release was submitted to SOURCE media through its business wire service. *** MARLBOROUGH –
Read more
Marlborough Company Highlights Bi-Polar & Schizophrenia Treatments at the American College of Neuropsychopharmacology Meeting
The following is a press release summitted to SOURCE media through its business wire service *** MARLBOROUGH- Sunovion Pharmaceuticals Inc. announced
Read more
Sunovion Marks 10th Anniversary
The following is a press release submitted to SOURCE media through its business wire service *** MARLBOROUGH – Sunovion Pharmaceuticals
Read more
Sunovion Announces Commercial Launch of KYNMOBI To Treat Parkinson’s Disease
The following is a press release from Marlborough-based Sunovion Pharmaceuticals submitted to SOURCE media through its business wire. *** MARLBOROUGH
Read more
Sunovion Announces Results from Global Phase 2 Bipolar Depression Study
The following is a press release *** MARLBOROUGH – Sunovion Pharmaceuticals Inc., today, July 6, announced results from its depressive,
Read more